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Francisella tularensis is a facultative intracellular pathogen that causes the disease tularemia. 
F . tularensis subsp. tularensis causes the most severe disease in humans and has been classified 
as a Category A select agent and potential bioweapon. There is currently no vaccine approved 
for human use, making genetic manipulation of this organism critical to unraveling the genetic 
basis of pathogenesis and developing countermeasures against tularemia.  The development of 
genetic techniques applicable to F . tularensis have lagged behind those routinely used for other 
bacteria, primarily due to lack of research and the restricted nature of the biocontainment required 
for studying this pathogen. However, in recent years, genetic techniques, such as transposon 
mutagenesis and targeted gene disruption, have been developed, that have had a dramatic 
impact on our understanding of the genetic basis of F . tularensis virulence. In this review, we 
describe some of the methods developed for genetic manipulation of F . tularensis.
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Despite these various obstacles, a number of recent advances 
have allowed for increasingly easier genetic manipulation in select 
agent forms of F. tularensis. Both random and directed mutagenesis 
can now be performed readily in F. tularensis subsp. tularensis, and 
several plasmids are available to facilitate complementation and 
expression studies. These tools are facilitating the illumination of 
the genetic basis of F. tularensis pathogenesis, and several of these 
will be discussed below.
Antibiotic resistAnce
Antibiotic resistance markers are critical for the development of 
genetic techniques. Genetic techniques utilizing various antibiotic 
resistance genes as selectable markers have been exploited in F. novi-
cida (Anthony et al., 1994; Gallagher et al., 2007; Liu et al., 2007; 
Rodriguez et al., 2008) but the use of antibiotic resistance in F. 
tularensis subsp. (with the exception of LVS) is restricted in the US. 
Resistance to any antibiotic that may be used therapeutically to treat 
tularemia (Urich and Petersen, 2008; Hofinger et al., 2009) may not 
be introduced into select agent forms of F. tularensis, which should 
preclude the introduction of resistance to chloramphenicol, cipro-
floxacin, levofloxacin, doxycycline, gentamicin, streptomycin, and 
tetracycline (Enderlin et al., 1994; Maurin et al., 2000; Antibiotic 
Selection Guide, 2004). This has restricted the use of antibiotic 
resistance markers to kanamycin, erythromycin, spectinomycin, 
rifampin, and hygromycin resistance in these organisms (LoVullo 
et al., 2006; Qin and Mann, 2006; Buchan et al., 2008; Kalivoda 
et al., 2010; Klose, unpublished data). These restrictions do not 
necessarily apply to scientists outside the US, and thus examples can 
be found in the published literature of other antibiotic resistance 
markers being introduced into, e.g., F. tularensis subsp. tularensis 
(Norqvist et al., 1996; Pomerantsev et al., 2001; Forslund et al., 
2006; Thomas et al., 2007).
Francisella tularensis/F. novicida strains are all highly resistant to 
ampicillin and other penicillin derivatives, and thus these antibiot-
ics are not used therapeutically to treat tularemia. Although two 
β-lactamases are encoded in the genome, only one of these, BlaB, 
introduction
Francisella tularensis is the causative agent of the human disease 
tularemia. Various subspecies of this organism have been described, 
with F. tularensis subsp. tularensis (also referred to as “Type A”) being 
the most virulent for humans. F. tularensis subsp. holarctica (also 
referred to as “Type B”) also causes serious disease in humans, and 
both subsp. tularensis and subsp. holarctica have been classified as 
category A select agents that require biosafety level 3 (BSL-3) con-
tainment for routine laboratory culture (McLendon et al., 2006). A 
closely related bacterium, F. novicida (also referred to as F. tularensis 
subsp. novicida, although it is not officially classified as a F. tularensis 
subsp.), is considered avirulent for healthy humans and can be main-
tained under BSL-2 conditions. A live attenuated vaccine strain (LVS) 
derived from F. tularensis subsp. holarctica is also avirulent for humans 
and can also be maintained under BSL-2 conditions (Eigelsbach and 
Downs, 1961). F. novicida and LVS cause lethal diseases in mice, and 
share similar pathogenic mechanism(s) as the select agent designated 
forms of F. tularensis, such as intramacrophage replication (Figure 1). 
Because F. novicida and LVS can be grown and maintained without 
the requirement for restrictive BSL-3 containment, these bacteria have 
been invaluable for the development of genetic manipulation tech-
niques and the dissection of virulence mechanisms of F. tularensis.
Initial techniques for genetic manipulation were developed in F. 
novicida, for the reasons given above, and the fact that F.   novicida 
has proven to be the most amenable of all Francisella spp. to genetic 
manipulation, for reasons that are not obvious. F. novicida is closely 
related to F. tularensis, as has become clear through whole genome 
sequencing (Rohmer et al., 2007; Champion et al., 2009), yet F. 
novicida can be transformed with linear DNA fragments which 
integrate into the chromosome through homologous recombina-
tion (Lauriano et al., 2003), a property that does not seem to apply 
to F. tularensis subsp. Additionally, use of antibiotic resistance mark-
ers is restricted in select agent strains of F. tularensis (discussed 
below), but not F. novicida. Taken together, this has allowed for a 
wider variety of techniques to be attempted in F. novicida than in 
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all F. tularensis subsp. The cryotransformation   protocol is: (a) F. 
tularensis/F. novicida cells are washed and resuspended into 0.2 M 
RbCl2; (b) DNA and cryotransformation buffer (10% Glycerol, 
10 mM HEPES, pH 6.5, 0.1 M Calcium chloride, and 10 mM RbCl2) 
are added to the cells and left on ice for 15 min; (c) the cells are then 
quick frozen in dry ice/ethanol bath for 5 min; (d) the cells are then 
thawed until at room temperature, and culture media is added and 
the mix is incubated for 2–3 h; (e) finally the cells are spread onto 
agar media with appropriate antibiotics (Liu et al., 2007; Rodriguez 
et al., 2008; Zogaj et al., 2008; Barker et al., 2009).
Electroporation is also commonly used for transformation into 
F. novicida/F. tularensis. There are reports indicating that electro-
poration is even more efficient than cryotransformation (LoVullo 
et al., 2006; Le Pihive et al., 2009). The typical protocol for electro-
poration of F. novicida/F. tularensis is (a) exponentially growing 
Francisella cells are centrifuged to concentrate them, (b) cells are 
washed three times and finally resuspended in 0.5 M sucrose, (c) 
DNA is mixed with cells for 10 min at RT, (d) cells are pulsed in 
electroporator (2.5 kV, 600 Ω, 25 μF), (e) culture media is added 
and the mix is incubated for 2–3 h, (f) finally the cells are spread 
onto agar media with appropriate antibiotics.
Chemical transformation is not commonly used in Francisella 
species, but was one of the first methods used to introduce DNA 
into F. novicida (Tyeryar and Lawton, 1969, 1970; Anthony et al., 
1991). On the other hand, the direct transfer of DNA from donor 
bacteria into F. novicida/F. tularensis via conjugation is becoming 
a common technique, and has been used to introduce DNA into 
the various Francisella spp. (Golovliov et al., 2003a, Forslund et al., 
2006; Mohapatra et al., 2007; Thomas et al., 2007). Transformation 
frequencies of approximately 1% in F. tularensis have been observed 
under optimal conditions when using E. coli donors to conjugate 
DNA (Golovliov et al., 2003a, Mohapatra et al., 2007). The con-
jugation procedure is simple: (a) incubate the donor E. coli and 
recipient F. novicida/F. tularensis cells together at 25°C for 18 h 
on non-selective agar medium (by cross-streaking or place both 
on filter), (b) transfer the mating mixture to selective medium 
and grown at 37°C to isolate desired recombinants. The selective 
medium typically contains antibiotic to select for the conjugated 
plasmid, and must also provide counter selection against the donor 
strain, e.g., polymyxin B (50–100 μg/ml) can be used to prevent 
the growth of E. coli without affecting the growth of F. tularensis 
(Frank and Zahrt, 2007).
PlAsmids
Plasmids are important for the development of various reporter 
constructs  and  in  trans  complementation  systems.  Commonly 
used plasmids in other bacteria, such as those with pUC, p15a, 
and pSC101 origins, do not replicate in F. novicida/F. tularensis; 
this property has been exploited in the development of F. tula-
rensis suicide plasmids, as described below. A plasmid, pFNL10, 
was isolated from F. novicida strain F6186 that can also replicate 
in F. tularensis (but is unable to replicate in, e.g., E. coli). Norqvist 
et al. modified this plasmid and added a p15a origin to allow rep-
lication in E. coli, resulting in the first F. tularensis shuttle vector, 
pKK202 (Norqvist et al., 1996; Frank and Zahrt, 2007). Many of the 
pKK202 derivatives contain tetracycline and/or chloramphenicol 
resistance markers, which are not allowed to be introduced into 
contributes in a significant manner to the ampicillin resistance of 
Francisella strains (Lauriano et al., 2003; Bina et al., 2006; LoVullo 
et al., 2006). This has allowed for the use of blaB as a selectable 
marker in a blaB− F. tularensis strain, thus expanding of the use 
of antibiotic resistance markers in select agent strains to include 
ampicillin (LoVullo et al., 2006).
trAnsformAtion
The first step to genetic manipulation is getting exogenous DNA 
into the bacterial cell. Host restriction/modification systems inhibit 
the acquisition of foreign DNA into the cell, and both F. novicida 
and F. tularensis subsp. tularensis have restriction enzymes that 
inhibit the acquisition of non-self DNA (Gallagher et al., 2008; 
Klose, unpublished data); interestingly, LVS has been reported to 
lack significant restriction against foreign DNA. Restriction of 
foreign DNA in F. novicida was eliminated by disruption of four 
different restriction enzymes (Gallagher et al., 2008), and this strain 
(MFN245) is ∼10,000-fold enhanced for transformation with for-
eign DNA. Because the modification systems are intact, MFN245 
can be used to transform with, e.g., plasmids, which can then be 
easily transformed in any F. novicida strain, due to the F. novicida-
specific modifications. F. tularensis subsp. tularensis restricts DNA 
from F. novicida, indicating it has different restriction/modifica-
tion systems (Klose, unpublished data), and thus transformation 
of MFN245 cannot be used to enhance subsequent transformation 
into F. tularensis subsp. tularensis.
Francisella novicida can be transformed with chromosomal DNA 
and linear fragments, indicating it likely has a natural competence 
system. The same is not true for the F. tularensis subsp., suggesting 
that natural competence was lost when F. novicida and F. tularensis 
diverged. There are several methods to transform F. novicida/F. 
tularensis. One of the most unique techniques for transforma-
tion is referred to as cryotransformation (Norqvist et al., 1996; 
Lauriano et al., 2003). Cryotransformation is a method that is easy 
to perform, and it has been shown to be effective in F. novicida and 
Figure 1 | Francisella novicida being released from a lysed macrophage. 
SEM image provided by M. Neal Guntzel and Annette R. Rogriguez.www.frontiersin.org  January 2011  | Volume 1  | Article 142  |  3
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that the pFNLTP and pMP vectors and the pKK202 derivatives 
arose from the same progenitor, pFNL10, and thus belong to the 
same incompatibility group.
A Francisella shuttle vector based on the replicon of a differ-
ent  incompatibility  group  has  been  constructed,  utilizing  the 
origin  from  the  Staphylococcus  aureus  pC194  plasmid,  along 
with the pUC ori. This plasmid, pCU18, can be maintained in 
F. novicida/F.   tularensis cells already carrying plasmids derived 
from pFNL10 (Rasko et al., 2007). This plasmid has not yet been 
adopted for widespread use in F. novicida/F. tularensis, and the 
presence of the chloramphenicol resistance marker prevents its 
usage in select agent forms of F. tularensis. However, additional 
shuttle vectors have recently been developed from F. philomiragia 
plasmids pF242 and pF243 (Le Pihive et al., 2009). pF242 is closely 
related to pC194, and can coexist in the same F. tularensis cells as 
pFNL10-based plasmids, and pF243 is closely related to pFNL10-
based plasmids. Useful shuttle vectors utilizing these origins of 
replication have been developed for F. tularensis with a variety of 
antibiotic resistance markers (Table 1).
Gene comPlementAtion
The pFNL10 derivative vectors discussed above have been used 
to achieve gene expression/complementation in trans. Researchers 
have typically either used native promoters for in trans expression, 
or frequently the F. tularensis groE promoter. The groE promoter 
was one of the first Francisella promoters identified for high-level 
expression within host cells (Ericsson et al., 1997), and this promoter 
has subsequently been utilized for expression of genes in trans, 
as well as antibiotic resistance markers (Forslund et al., 2006). 
select agent forms of F. tularensis in the US. In our laboratory (e.g., 
pKEK1140; see below) and others’, these markers have been replaced 
with kanamycin resistance, which allows these pKK202 derivatives 
to be used in F. tularensis subsp. tularensis (LoVullo et al., 2006; 
Buchan et al., 2008).
It  is  difficult  to  transform  pKK202  derivatives  into  several 
F.   tularensis subsp., leading Maier et al. to create a new shuttle vector 
by first selecting for pFNL10 derivatives that would replicate better 
in LVS, which resulted in the deletion of a portion of the pFNL10 
plasmid present in pKK202 encoding an apparent toxin–antitoxin 
system (ORF4–ORF5). This “modified” Francisella ori is the basis 
for the pFNLTP series of plasmids, which also contain the pUC ori 
for replication in E. coli, as well as kanamycin resistance for use in 
select agent forms of F. tularensis. The pFNLTP shuttle vectors have 
high transformation efficiency in LVS and contain multiple cloning 
sites (Maier et al., 2004). Additionally, these researchers identified 
a temperature-sensitive allele in the replicon that has become an 
extremely useful tool for removal of pFNL10-based plasmids from 
Francisella strains.
LoVullo  et  al.  (2006,  2009)  have  constructed  a  series  of 
Francisella shuttle vectors (pMP series) with varying portions of 
pFNL10. These studies established that shuttle vectors containing 
the ori, repA, and ORF2 regions of pFNL10, along with kanamycin 
resistance expressed from the Francisella groEL promoter, can be 
transformed at high efficiency into F. tularensis strains. Moreover, 
the addition of either the ORF4–ORF5 toxin–antitoxin system, or 
ORF3 (which increases plasmid copy number within the cell) from 
pFNL10 to the shuttle vector allowed for stable maintenance of the 
plasmid in the absence of antibiotic selection. It should be noted 
Table 1 | Francisella tularensis useful plasmids.
Plasmids Attributes reference
pKK202 pFNL10-based plasmid; also contains p15a ori; TetR; CmR Norqvist et al. (1996)
pFNLTP plasmids pFNL10-based plasmid; also contains pUC ori; KanR Maier et al. (2004)
pMP plasmids (series 1) pFNL10-based plasmids; stable and unstable variants; also contain colE1 ori; 
KanR or HygR
LoVullo et al. (2006)
pMP plasmids (series 2) pFNL10-based plasmids; stable and unstable variants; increased/decreased copy 
number variants; also contain colE1 ori; KanR or HygR
LoVullo et al. (2009)
pCU18 pC194-based plasmid; also contains pUC ori; AmpR, CmR Rasko et al. (2007)
pF242 plasmids pF242-based plasmids; contain either p15a or pUC ori; KanR or CmR or TetR  Le Pihive et al. (2009)
pF243 plasmids pF243-based plasmids; contain either p15a or pUC ori; KanR or CmR or TetR Le Pihive et al. (2009)
pKK214 Derived from pKK202; promoter trap vector drives CmR; TetR Kuoppa et al. (2001)
pKK214GFP/ASV Destabilized GFP expressed from groELp in pKK214, TetR Abd et al. (2003)
pF242-gfp-Cm GFP expressed from groELp in pF242-based plasmid, CmR Le Pihive et al. (2009)
pXB173-lux P . luminescens lux operon expressed from groELp in pFNL10-based plasmid, KmR Bina et al. (2010)
pBB107 Tn5 transposon delivery plasmid for mutagenesis of F . tularensis; KmR Buchan et al. (2008)
pHimar H3 HimarFT transposon delivery plasmid for mutagenesis of F . tularensis; KmR Maier et al. (2006)
pKEK1140 Targetron plasmid, intron expressed from groELp in pFNL10-based plasmid; KmR Rodriguez et al. (2008)
pPV Suicide vector for allelic replacement in F . tularensis; sacB; CmR Golovliov et al. (2003a,b)
pMP590 Suicide vector for allelic replacement in F . tularensis; sacB; KanR LoVullo et al. (2006)
pJC84 Suicide vector for allelic replacement in F . tularensis; sacB; KanR Rodriguez et al. (2008), Wehrly et al. (2009)
pJH1 and pGUTS Plasmids to facilitate allelic replacement in F . tularensis via I-SceI restriction Horzempa et al. (2010)
pKEK1286 and 
pKEK1287
Gateway-compatible cloning vectors for bacterial 2-hybrid system Karna et al. (2010)Frontiers in Microbiology  |  Cellular and Infection Microbiology    January 2011  | Volume 1  | Article 142  |  4
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The Manoil laboratory utilized a EZ::TN-based approach to 
create a comprehensive transposon mutant library in F. novi-
cida.  Through  saturation  mutagenesis  and  high-throughput 
sequencing, these researchers were able to identify 396 genes that 
lacked Tn insertions, indicating that these are essential genes. An 
important observation during this effort was that the antibiotic 
resistance gene present in the transposon requires a Francisella 
promoter to achieve truly random insertion in non-essential 
genes. The resulting comprehensive library contains at least two 
independent Tn insertions in each of the 1,490 non-essential 
F. novicida genes. This library is a valuable resource that has 
been subsequently used to identify genes involved in virulence 
(Gallagher et al., 2007).
Variants  of  the  EZ::TN  transposon  have  been  created  that 
contain additional elements, including FRT sites for subsequent 
excision of the antibiotic resistance gene via FLP-mediated recom-
bination (Gallagher et al., 2007), R6Kγori, a conditional origin of 
replication that is used to rescue the transposon after insertion into 
the genome (Qin et al., 2004), and outward facing T7 promoters 
to facilitate identification of the insertion site (Tempel et al., 2006; 
Weiss et al., 2007).
A further variation on Tn5-based mutagenesis was the devel-
opment of a plasmid delivery system for transposon mutagenesis. 
The Tn5-based transposon, rather than being directly transformed 
as a transposon–transposase complex, is instead delivered on the 
plasmid pBB107, which is a shuttle vector that also contains the 
transposase under inducible control, as well as a temperature-
  sensitive pFNL10-based ori (Maier et al., 2004; Buchan et al., 2008); 
following Tn insertion into the chromosome the plasmid can be 
removed with elevated temperature. Variants of this transposon 
contain additional useful attributes, including FLP recombination 
sites, the R6K ori, and transcriptional reporters (luxCDABE and 
lacZ; Buchan et al., 2008).
The  Himar-based  transposons  are  characterized  to  exhibit 
the most random insertion of all known transposons, due to the 
minimal 2 bp recognition sequence (AT) utilized by this transpo-
son. Due to the AT-rich nature of the F. tularensis genome, Himar 
transposons would be predicted to be particularly useful, and a 
Himar1-based transposon has been developed for use in Francisella 
(HimarFT). HimarFT was used to create transposon mutants in 
LVS (Maier et al., 2006), which allowed for the identification of 
additional virulence genes (Maier et al., 2007).
tArGeted Gene disruPtion
Targeted gene disruption is one of the major goals when developing 
genetic techniques for any organism. F. novicida is readily manipu-
lated to quickly inactivate target genes in techniques that rely on 
double homologous recombination, primarily due to its ability to 
be transformed with linear DNA. However, the techniques utiliz-
ing this capability in F. novicida have failed to work in F. tularensis, 
as mentioned above. Still, techniques are available to specifically 
inactivate genes in F. tularensis through a two-step process, where 
the first homologous recombination event is selected through posi-
tive selection, and the second homologous recombination event is 
counter selected. An alternative technique involving inactivation 
by retargeted Group II introns has also been developed that works 
efficiently in F. tularensis strains.
Another   promoter identified for high-level expression in F. novicida 
in vivo is that for FTN1451, which encodes a protein of unknown 
function (Gallagher et al., 2007); the FTN1451 promoter has been 
used to drive high-level expression of antibiotic resistance mark-
ers in various F. tularensis strains (Liu et al., 2007). Full comple-
mentation of chromosomal mutations utilizing these promoters 
to drive in trans expression off a pFNL10 derivative plasmid has 
been notoriously difficult in Francisella strains, especially in tissue 
culture. This incomplete complementation is likely due to a com-
bination of increased copy number due to the relatively high-copy 
number plasmid, non-native expression due to the groE   promoter 
being  used,  and  possibly  instability  of  plasmids  lacking  the   
toxin–antitoxin system.
The copy number effect of in trans complementation can be 
overcome by in cis complementation, by introducing the expression 
construct onto the Francisella chromosome. The first examples of 
complementation in Francisella involved in cis complementation, 
but this technique has not subsequently been utilized extensively, 
although there are notable examples of its use in F. novicida, as well 
as in F. tularensis subsp. holarctica (Mdluli et al., 1994; Baron and 
Nano, 1998; Forslund et al., 2006; de Bruin et al., 2007). A technique 
for in cis complementation in F. novicida has been developed that 
targets the FTN_1758 gene (de Bruin et al., 2007); because this 
gene is not found in F. tularensis strains this method is not appli-
cable for use in these organisms. LoVullo et al. (2009) have recently 
developed two systems for in cis complementation in F. tularensis, 
using suicide vectors to target a Tn7 insertion site near the glmS 
gene, and to replace the blaB gene.
rAndom mutAGenesis
Transposon-mediated random mutagenesis is an invaluable tool for 
the generation of populations of mutant bacteria, which can then be 
screened for the phenotype of interest; the mutated gene can then be 
easily identified by the identification of the location of the transpo-
son. The first transposon mutants were constructed in F.   novicida, 
utilizing a Tn5-based transposon to mutagenize F.   novicida DNA 
that was subsequently used to transform F.   novicida, which resulted 
in  the  identification  of  genes  important  for  intramacrophage 
growth and virulence (Baron and Nano, 1998). While this first study 
was successful, the technique was cumbersome and only applicable 
to F. novicida, and the transposon was discovered to be unstably 
integrated (Lauriano et al., 2003).
A major milestone was achieved with the creation of the first 
transposon mutants in LVS, utilizing the Tn5 derivative transpo-
son EZ::TN Kan (Kawula et al., 2004). This technique uses a Tn5-
based transposon complexed with transposase, which is introduced 
directly into the Francisella cells via transformation; once the com-
plex enters the cell, the transposase mediates random insertion of 
the transposon into the chromosome. The transposon insertion 
frequency is high and allowed for the creation of a large pool of 
Tn mutants in LVS (Kawula et al., 2004). A further adaptation of 
this technique was used to generate “tagged” transposons for a 
signature-tag mutagenesis study of LVS (Kawula et al., 2004; Su 
et al., 2007). Derivatives of the Tn5-based EZ::TN transposon have 
since been used to make transposon mutant libraries in F. novicida 
and F. tularensis subsp. tularensis (Qin et al., 2004; Qin and Mann, 
2006; Weiss et al., 2007).www.frontiersin.org  January 2011  | Volume 1  | Article 142  |  5
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  recognition sequence, such that the restriction site is not normally 
found in the chromosomal sequence. By first allowing a deletion 
construct in a suicide plasmid with a I-SceI site (pJH1) to inte-
grate into the F. tularensis chromosome, and then transforming 
this merodiploid strain with a plasmid that expresses the I-SceI 
enzyme (pGUTS), these researchers were able to generate F. tularen-
sis strains with unmarked deletions in the chromosome (Horzempa 
et al., 2010).
An alternate strategy for targeted gene inactivation in F.   tularensis 
has been developed that utilizes group II intron insertion into the 
gene of interest. Group II introns form a ribonucleoprotein com-
plex that targets the site for insertion by basepairing between the 
RNA and the chromosomal DNA. Thus Group II introns can be 
retargeted to insert at specific sites by altering the sequence of the 
RNA component, and this technique (referred to as Targetron) 
has been exploited to disrupt genes in Gram-positive and Gram-
negative bacteria (Karberg et al., 2001; Frazier et al., 2003; Perutka 
et al., 2004; Chen et al., 2005; Yao et al., 2006; Rodriguez et al., 
2008, 2009). Our laboratory has optimized this technique for use 
in F. tularensis (Rodriguez et al., 2008, 2009), which involves (a) 
identification of target sites in specific gene sequence via computer 
algorithm, (b) “retargeting” the Group II intron via PCR and subse-
quent cloning into Targetron plasmid (pKEK1140), (c) transforma-
tion of Targetron plasmid into F. tularensis, (d) screen colonies for 
insertion of intron into target gene, and (e) remove temperature-
sensitive Targetron plasmid by growth at elevated temperature. The 
ribonucleoprotein complex functions independent of host recom-
bination machinery, so the key to this technique functioning in any 
given organism is achieving expression of the ribonucleoprotein 
complex, which is accomplished by a Francisella promoter.
This technique has several advantages, including the continu-
ous expression of the ribonucleoprotein complex within the cells, 
which leads to efficient target site insertion. Also, the intron lacks 
an antibiotic resistance marker, which is advantageous when work-
ing with select agent strains of F. tularensis. Finally, this technique 
allows for the inactivation of two identical genes simultaneously, 
which has allowed for simultaneous inactivation of both copies 
of the duplicated FPI genes in F. tularensis subsp. tularensis. The 
disadvantage of this technique is that it results in an insertion in, 
not a deletion of, the gene of interest, which may affect downstream 
gene expression.
rePorter constructs
Plasmids and transposons can be engineered to serve as reporters of 
gene expression, and a number of these genetic constructs now exist 
to facilitate the study of F. tularensis pathogenesis. The first attempt 
to identify genes upregulated during F. tularensis growth inside cells 
utilized a promoter “trap” construct in which chromosomal DNA 
fragments were cloned in the plasmid pKK214 (Kuoppa et al., 2001), 
to identify promoters that drive expression of a chloramphenicol 
reporter gene, which led to survival in chloramphenicol-treated host 
cells. This initial study led to the identification of the groE promoter, 
which is still used to drive expression of various genes in F. tularen-
sis constructs. Additional studies have also utilized this construct 
(Baron et al., 1999; Abd et al., 2003), but restrictions on antibiotic 
resistance prevent its usage in select agent forms of F.   tularensis 
in the US. Promoter trap plasmids have also been developed for 
Genes in F. novicida can be inactivated by transformation with 
linear PCR products that consist of an antibiotic resistance gene 
flanked by at least 500 bp of flanking homology to the gene of inter-
est (Lauriano et al., 2003; Liu et al., 2007). Increasing the amount of 
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by addition of the lambda proteins (Aguiar et al., 2004; Gao et al., 
2008; Matsuyama and Yoshida, 2009). A complete Gateway® entry 
clone set representing all the ORFs from the F. tularensis subsp. 
tularensis genome has been constructed and is available through the 
Pathogen Functional Genomics Resource Center (PFGRC; http://
pfgrc.jcvi.org/). The only thing limiting broad use of this clone 
set is a lack of appropriate destination vectors modified for use 
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compatible bacterial 2-hybrid system that can be used to study 
the interactions between proteins, and demonstrated that it can 
be used to detect interactions between F. tularensis ORFs present 
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PersPective
Genetic techniques and tools for the study of F. tularensis have 
expanded dramatically in the past several years. With this new 
arsenal of methods, the near future should represent the “golden 
age” of the study of the genetic basis of F. tularensis pathogenesis. 
This will afford greater insight into why F. tularensis is able to cause 
disease and evade host immune mechanisms, and ultimately lead 
to novel ways to prevent and treat tularemia.
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